Clinical Trials Directory

Trials / Sponsors / F2G Biotech GmbH

F2G Biotech GmbH

Industry · 20 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingOlorofim Aspergillus Infection Study
Invasive Aspergillosis
Phase 32022-03-31
CompletedA Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment
Renal Impairment
Phase 12022-02-10
CompletedA Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment
Hepatic Impairment
Phase 12021-07-02
CompletedA Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim
Healthy
Phase 12019-12-05
CompletedDrug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim
Healthy
Phase 12019-11-18
CompletedAbsorption, Metabolism and Excretion of 14C-olorofim in Man
Invasive Fungal Infections
Phase 12019-07-30
WithdrawnRadiolabelled IV and Oral Metabolism Study of F901318
Invasive Aspergillosis
Phase 12019-05-01
CompletedEvaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options
Invasive Fungal Infections
Phase 22018-06-06
CompletedAssessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects
Invasive Aspergillosis
Phase 12017-12-12
WithdrawnDrug/Drug Interactions With F901318
Invasive Aspergillosis
Phase 12017-05-01
WithdrawnPharmacokinetics of IV Formulation
Invasive Aspergillosis
Phase 12017-05-01
WithdrawnStudy on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
Pulmonary Aspergillosis - Invasive, Acute Myeloid Leukemia
Phase 1 / Phase 22017-04-20
WithdrawnSafety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia
Acute Myeloid Leukemia
Phase 1 / Phase 22017-03-01
CompletedEvaluation of Immediate Release Tablet
Invasive Aspergillosis
Phase 12016-07-01
CompletedMultiple Ascending Oral Dose Study of F901318 in Healthy Subjects
Invasive Aspergillosis
Phase 12016-05-01
CompletedStudy of Potential for Interaction of Fluconazole With F901318
Invasive Aspergillosis
Phase 12016-02-01
CompletedEvaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe
Invasive Aspergillosis
Phase 12016-01-01
CompletedSingle Ascending Oral Dose Study of F901318
Invasive Aspergillosis
Phase 12015-10-01
CompletedF901318 Multiple Ascending Dose Study
Invasive Aspergillosis
Phase 12015-02-01
CompletedF901318 Single Ascending Dose Study in Healthy Male Volunteers
Invasive Aspergillosis
Phase 12014-08-01